Erlotinib, Gemcitabine and Nab-Paclitaxel in Advanced Pancreatic Cancer
| Status: | Archived |
|---|---|
| Conditions: | Cancer, Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 7/1/2011 |
| Start Date: | December 2009 |
| End Date: | September 2011 |
A Phase IB Study of Erlotinib in Combination With Gemcitabine and Nab-Paclitaxel in Patients With Previously Untreated Advanced Pancreatic Cancer
This is a phase 1b study to evaluate the combination of gemcitabine and Tarceva (erlotinib)
and Nab-Paclitaxel in patients with advanced pancreatic cancer.
This is a single-arm, phase 1b study to determine the maximum tolerated dose (MTD) of the
combination of erlotinib (daily), gemcitabine (weekly), nab-paclitaxel (weekly) in patients
with advanced pancreatic cancer.
We found this trial at
5
sites
101 Manning Dr
Chapel Hill, North Carolina 27599
Chapel Hill, North Carolina 27599
(919) 966-4131
University of North Carolina Hospital at Chapel Hill The UNC Health Care System is a...
Click here to add this to my saved trials
13001 E. 17th Pl.
Aurora, Colorado 80045
Aurora, Colorado 80045
303-724-5000
University of Colorado Cancer Center - Anschutz Cancer Pavilion The University of Colorado Denver |...
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Fox Chase Cancer Center Fox Chase has earned the prestigious designation from the National Cancer...
Click here to add this to my saved trials